Morpholino

MO1-sfxn1

ID
ZDB-MRPHLNO-211206-3
Name
MO1-sfxn1
Previous Names
None
Target
Sequence
5' - CACACTGTGGAGAGATTACACTGGT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-sfxn1
Phenotype
Phenotype resulting from MO1-sfxn1
Phenotype Fish Figures
nucleate erythrocyte hbbe1.1 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
nucleate erythrocyte hbae1.1 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
nucleate erythrocyte hbbe3 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
nucleate erythrocyte alas2 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 4 from Bao et al., 2021
nucleate erythrocyte hbbe2 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
nucleate erythrocyte hbae3 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
nucleate erythrocyte gata1a expression increased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
nucleate erythrocyte gata1a expression increased distribution, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
nucleate erythrocyte alas2 expression increased distribution, abnormal AB + MO1-sfxn1 Fig. 4 from Bao et al., 2021
nucleate erythrocyte hemoglobin decreased amount, abnormal AB + MO1-sfxn1 Fig. 2Fig. 4Fig. 5 from Bao et al., 2021
nucleate erythrocyte nucleus increased ratio nucleate erythrocyte cytoplasm, abnormal AB + MO1-sfxn1 Fig. 3Fig. 5 from Bao et al., 2021
whole organism hbae1.1 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
whole organism alas2 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 4 from Bao et al., 2021
whole organism hbae3 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
whole organism hbbe2 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
whole organism hbbe1.1 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
whole organism hbbe3 expression decreased amount, abnormal AB + MO1-sfxn1 Fig. 3 from Bao et al., 2021
Phenotype of all Fish created by or utilizing MO1-sfxn1
Phenotype Fish Conditions Figures
nucleate erythrocyte hbbe1.1 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
whole organism hbbe1.1 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
whole organism hbbe2 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
whole organism alas2 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 4 from Bao et al., 2021
nucleate erythrocyte hemoglobin amount, ameliorated AB + MO1-sfxn1 chemical treatment by environment: pyridoxine Fig. 5 from Bao et al., 2021
nucleate erythrocyte hbbe2 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte alas2 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 4 from Bao et al., 2021
nucleate erythrocyte hemoglobin decreased amount, abnormal AB + MO1-sfxn1 control Fig. 2Fig. 4Fig. 5 from Bao et al., 2021
whole organism hbbe3 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte nucleus increased ratio nucleate erythrocyte cytoplasm, abnormal AB + MO1-sfxn1 control Fig. 3Fig. 5 from Bao et al., 2021
nucleate erythrocyte hemoglobin amount, ameliorated AB + MO1-sfxn1 chemical treatment by environment: 5-aminolevulinate Fig. 5 from Bao et al., 2021
whole organism hbae3 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte hbae1.1 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte nucleus ratio nucleate erythrocyte cytoplasm, ameliorated AB + MO1-sfxn1 chemical treatment by environment: 5-aminolevulinate Fig. 5 from Bao et al., 2021
nucleate erythrocyte hbae3 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte hbbe3 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte gata1a expression increased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
whole organism hbae1.1 expression decreased amount, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte gata1a expression increased distribution, abnormal AB + MO1-sfxn1 control Fig. 3 from Bao et al., 2021
nucleate erythrocyte alas2 expression increased distribution, abnormal AB + MO1-sfxn1 control Fig. 4 from Bao et al., 2021
Citations